Canaccord Genuity Maintains Buy on Omada Health, Raises Price Target to $28
Omada Health, Inc.
Omada Health, Inc. OMDA | 0.00 |
Canaccord Genuity analyst Richard Close maintains Omada Health (NASDAQ:
OMDA) with a Buy and raises the price target from $24 to $28.
